TrademarkDir
DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY
LIVE

Serial Number

98090566

Owner

NanoVation Therapeutics Inc.

Attorney

Jeffrey A. Smith

Filing Date

Jul 18, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY Trademark

Serial Number: 98090566

DELIVERING TOMORROW'S GENETIC MEDICINES, TODAY is a trademark filed by NanoVation Therapeutics Inc. on July 18, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

NanoVation Therapeutics Inc. (6 trademarks)

2405 Westbrook Mall, 4th Floor

Entity Type: 03

Trademark Details

Filing Date

July 18, 2023

Registration Date

Not Registered

Goods & Services

Lipid-based delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of nucleic acid for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders associated with aging

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 27, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 27, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jul 27, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 14, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 15, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 15, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 15, 2026 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 18, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 18, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 18, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2025 CRFA
ASSIGNED TO LIE
Jul 9, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 25, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 25, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 25, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 25, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 24, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 24, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 24, 2024 CNSL
EXAMINER'S AMENDMENT ENTERED
Sep 24, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 24, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 24, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 24, 2024 CNEA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 23, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 23, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 23, 2024 CNSL
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 14, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 14, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 23, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 16, 2023 NWOS
NEW APPLICATION ENTERED
Jul 21, 2023 NWAP

Related Trademarks

More from this Owner

NVTX

NVTX

NVTX

NVTX

LCLNP

LCLNP

LCLNP

LCLNP

LCLNP

LCLNP

NANOVATION THERAPEUTICS

NANOVATION THERAPEUTICS